| Literature DB >> 32854688 |
Eivind Andersen1, Gry Bang-Kittilsen2, Therese Torgersen Bigseth2, Jens Egeland2,3, Tom Langerud Holmen2, Egil Wilhelm Martinsen4,5, Trine Stensrud6, John Abel Engh2.
Abstract
BACKGROUND: Exercise may improve cardiorespiratory fitness in people with schizophrenia, however, possible condition-specific cardiorespiratory disadvantages, a scarcity of methodologically sound studies, and conflicting results raise questions about the effect of exercise on maximal oxygen uptake (VO2max) in this group. The primary aim of this study, therefore, was to investigate the effect of high-intensity interval training on VO2max in people with schizophrenia. Second, we sought to determine whether the intervention would have an effect on general physical activity (PA) level and body composition. <br> METHODS: Eighty-two patients with schizophrenia were randomly assigned to supervised high-intensity interval training or computer gaming skills training, performed twice a week for 12 weeks. Oxygen uptake was measured directly, during a maximum exercise session on a treadmill. PA level were assessed using ActiGraph accelerometer, and body composition was assessed by bioelectrical impedance. Differences between groups were assessed by analysis of variance using a univariate general linear model. <br> RESULTS: There were no significant differences between the groups on any of the cardiorespiratory variables neither at baseline nor after the program. There were also no significant within-group differences in any of the cardiorespiratory fitness variables between the baseline and post-program time points, despite that 61% of the participants performing high-intensity interval training showed a significant increase in workload on the treadmill. However, 47% of the participants in the high-intensity interval training group had a ≥ 5% increase in VO2max. Participants supervised by mental health care providers with PA competence (e.g. rehabilitation center staff, sport scientist, physical trainer) had a much larger increase in VO2max compared to participants supervised by mental health workers without such competence, and when adding PA competence to the model, the intervention group increased VO2max significantly compared to the comparison group. The intervention had no significant effect on PA level or body composition. <br> CONCLUSIONS: The intervention did not improve VO2max, PA level or body composition but succeeded in increasing workload on the treadmill. With regard to VO2max, approximately half of the patients may be considered responders. TRIAL REGISTRATION: ClinicalTrials.gov ; NCT02205684 , registered July 2014.Entities:
Keywords: Exercise; Maximal oxygen uptake; Physical activity; RCT; Schizophrenia
Mesh:
Year: 2020 PMID: 32854688 PMCID: PMC7457274 DOI: 10.1186/s12888-020-02827-2
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Fig. 1EPHAPS trial flowchart
Baseline sociodemographic and clinical characteristics for both groups
| Characteristics | Intervention group ( | Comparison group ( |
|---|---|---|
| Female (%) | 39 | 38 |
| Age (years) | 36 (14) | 37 (13) |
| PANSS | ||
| Total | 68 (16) | 63 (16) |
| Negative | 19 (7) | 17 (6) |
| Positive | 15 (5) | 14 (5) |
| Duration of illness (years) | 15 (11) | 15 (13) |
| Antipsychotics (DDD)* | 1.8 (1.0) | 1.3 (0.7) |
| Smokers (%) | 62 | 71 |
| Education level (%) | ||
| Primary school | 44 | 41 |
| High school | 37 | 28 |
| College/university | 18 | 30 |
| Employed at least 50% of full time (%) | 11 | 10 |
| Married or living with a partner (%) | 14 | 13 |
Presented values are the mean ± SD if not specified otherwise. DDD, defined daily doses. PANSS; Positive and Negative Syndrome Scale. * Significant difference between groups (P ≤ 0.05)
Between-group difference in cardiorespiratory responses to maximal exercise at baseline and post-program
| Intervention group | Comparison group | |||||||
|---|---|---|---|---|---|---|---|---|
| N | Mean (SD) | N | Mean (SD) | Mean diff | 95% CI | P | ||
| VO2max (L·min− 1) | Baseline | 34 | 2.7 (0.7) | 27 | 2.5 (0.9) | 0.05 | 0.2, −0.3 | 0.7 |
| Post-program | 20 | 2.7 (0.9) | 26 | 2.6 (0.9) | 0.1 | 0.3, − 0.1 | 0.3 | |
| VO2max (mL∙kg−1∙min−1) | Baseline | 34 | 32.1 (11) | 27 | 31.1 (11) | 0.9 | 3.6, −5.5 | 0.7 |
| Post-program | 21 | 30.8 (11) | 26 | 31.1 (11) | −1.8 | −4.4, 0.8 | 0.17 | |
| VO2max (mL∙kgFFM−1∙min− 1) | Baseline | 34 | 44.8 (12) | 27 | 42.6 (12) | 0.2 | 5.5, −4.9 | 0.9 |
| Post-program | 20 | 43.4 (12) | 26 | 43.2 (12) | 1.7 | 5.6, −2.1 | 0.3 | |
| RER (VCO2/VO2) | Baseline | 34 | 1.09 (0.05) | 27 | 1.09 (0.06) | 0.00 | 0.02, −0.04 | 0.5 |
| Post-program | 21 | 1.10 (0.07) | 26 | 1.08 (0.06) | 0.01 | 0.05, −0.02 | 0.3 | |
| Maximal heart rate (beats·min− 1) | Baseline | 34 | 174 (22) | 27 | 170 (17) | 0.4 | 8, −7 | 0.9 |
| Post-program | 20 | 173 (20) | 26 | 169 (13) | 1.8 | 5.4, −1.7 | 0.3 | |
| Ventilation (L∙min− 1) | Baseline | 29 | 94 (29) | 22 | 84 (30) | 2.0 | −16, 12 | 0.7 |
| Post-program | 21 | 88 (27) | 24 | 85 (25) | 3.8 | −13, 5 | 0.4 | |
| Oxygen pulse (mL∙beats− 1) | Baseline | 34 | 15.5 (3.9) | 27 | 14.5 (4.7) | 0.4 | 2.3, −1.3 | 0.5 |
| Post-program | 19 | 16.0 (4.3) | 25 | 15.2 (5.1) | 0.6 | 2.0, −0.7 | 0.3 | |
| Resting heart rate (beats∙min− 1) | Baseline | 34 | 75 (12) | 27 | 75 (16) | 0.9 | 8, −6 | 0.7 |
| Post-program | 21 | 75 (13) | 24 | 72 (14) | 0.4 | 7, −6 | 0.8 | |
| Heart rate reserve (beats∙min−1) | Baseline | 34 | 98 (25) | 27 | 94 (26) | 0.5 | 10, −11 | 0.9 |
| Post-program | 19 | 97 (21) | 23 | 97 (23) | 1.2 | 8.8, −6.4 | 0.7 | |
Presented values are the mean ± SD. VO2max, peak oxygen uptake. FFM, fat-free mass. RER, respiratory exchange ratio. CI, confidence interval
Work capacity measured at interval number three in weeks 4 and 12 in the group performing high-intensity interval training
| Mean (SD) | Mean diff | 95% CI | P | ||
|---|---|---|---|---|---|
| Treadmill speed (km/h) | Week 4 | 6.1 (2.2) | 0.5 | 0.2, 0.9 | 0.002 |
| Week 12 | 6.7 (2.8) | ||||
| Treadmill inclination (%) | Week 4 | 4.1 (2.8) | 1.6 | 0.2, 2.9 | 0.02 |
| Week 12 | 5.7 (5.1) | ||||
| Heart rate (beats/min) | Week 4 | 155 (21) | 3.9 | 0.8, 7.1 | 0.01 |
| Week 12 | 159 (22) |
N = 36. Presented values are the mean ± SD. CI, confidence interval
Between-group differences in pulmonary function at baseline and post-program
| Intervention group | Comparison group | |||||||
|---|---|---|---|---|---|---|---|---|
| N | Mean (SD) | N | Mean (SD) | Mean diff | 95% CI | P | ||
| FVC (L) | Baseline | 43 | 4.4 (1.3) | 39 | 4.2 (1.1) | 0.2 | −0.3, 0.7 | 0.4 |
| Post-program | 32 | 4.3 (1.3) | 37 | 4.2 (1.1) | 0.0 | −0.5, 0.6 | 0.7 | |
| FVC % pred (%) | Baseline | 100 (20) | 96 (15) | 3.3 | −4.9, 11.6 | 0.4 | ||
| Post-program | 99 (17) | 98 (14) | −1.3 | −8.5, 5.9 | 0.7 | |||
| FEV1 (L) | Baseline | 43 | 3.4 (1.0) | 39 | 3.3 (1.0) | 0.1 | −0.3, 0.6 | 0.5 |
| Post-program | 32 | 3.3 (1.0) | 37 | 3.1 (0.9) | 0.1 | −0.3, 0.6 | 0.4 | |
| FEV1 pred (%) | Baseline | 93 (16) | 90 (19) | 2.7 | −56, 11.1 | 0.5 | ||
| Post-program | 93 (18) | 89 (17) | 1.8 | −5.8, 9.6 | 0.6 | |||
| FEV1/FVC (%) | Baseline | 42 | 77 (11) | 37 | 77 (10) | −0.1 | −4.9, 4.6 | 0.9 |
| Post-program | 32 | 78 (8) | 37 | 75 (11) | 2.5 | −2.2, 7.3 | 0.2 | |
| FEV1/FVC pred (%) | Baseline | 95 (13) | 95 (12) | −0.3 | −6.2, 5.6 | 0.9 | ||
| Post-program | 96 (9) | 93 (14) | 3.7 | − 2.2, 9.7 | 0.2 | |||
| MEF50 (L· s−1) | Baseline | 42 | 3.9 (1.5) | 37 | 3.9 (1.4) | 0.0 | −0.5, 0.7 | 0.8 |
| Post-program | 32 | 3.8 (1.6) | 37 | 3.4 (1.3) | 0.4 | −0.3, 1.1 | 0.2 | |
| MEF50 pred (%) | Baseline | 78 (25) | 78 (25) | 0.2 | −11.6, 12.1 | 0.9 | ||
| Post-program | 78 (27) | 70 (25) | 8.0 | −5.0, 21 | 0.2 | |||
| MVV (L) | Baseline | 40 | 120 (37) | 37 | 114 (36) | 5.7 | −11, 22 | 0.5 |
| Post-program | 32 | 118 (37) | 35 | 110 (31) | 7.8 | −9, 24 | 0.3 | |
| BR (%) | Baseline | 37 | 26 (18) | 32 | 22 (26) | 4.2 | −7, 15 | 0.4 |
| Post-program | 25 | 21 (20) | 27 | 20 (23) | 0.8 | −11, 13 | 0.8 | |
Presented values are the mean ± SD. SD, standard deviation. CI, confidence interval. Pred, predicted. FVC, forced vital capacity. FEV1, forced expiratory volume in 1 s. MEF 50%, maximal expiratory flow 50%. MVV, maximal voluntary ventilation. BR, breathing reserve
Between-group differences in physical activity level and sedentary time at baseline and post-program
| Intervention group | Comparison group | |||||||
|---|---|---|---|---|---|---|---|---|
| N | Mean (SD) | N | Mean (SD) | Mean diff | 95% CI | P | ||
| Number of valid days | Baseline | 35 | 3.4 (1.0) | 35 | 3.4 (1.2) | 0.0 | −0.5, 0.6 | 0.8 |
| Post-program | 23 | 3.1 (1.1) | 25 | 3.1 (1.0) | −0.0 | − 0.6, 0.6 | 0.9 | |
| Wear time (min∙day−1) | Baseline | 35 | 10.3 (2.9) | 35 | 10.7 (3.1) | −0.3 | −1.9, 1.1 | 0.6 |
| Post-program | 23 | 10.6 (2.3) | 25 | 10.8 (2.8) | −0.2 | −1.7, 1.3 | 0.7 | |
| Total PA level (CPM) | Baseline | 33 | 220 (91) | 34 | 255 (157) | −35 | −97, 26 | 0.25 |
| Post-program | 22 | 246 (154) | 25 | 281 (198) | −34 | − 121, 52 | 0.4 | |
| Light PA (min∙day− 1) | Baseline | 35 | 202 (90) | 35 | 205 (91) | −2.6 | −40, 34 | 0.8 |
| Post-program | 23 | 226 (92) | 25 | 199 (78) | 27 | −13, 68 | 0.18 | |
| Moderate PA (min∙day− 1) | Baseline | 35 | 19 (12) | 35 | 26 (23) | −7.0 | −16, 2.6 | 0.15 |
| Post-program | 23 | 24 (18) | 25 | 21 (21) | 2.7 | −0.5, 11 | 0.5 | |
| Vigorous PA (min∙day−1) | Baseline | 35 | 0.6 (2.1) | 35 | 1.4 (3.7) | −0.8 | −2.3, 0.7 | 0.3 |
| Post-program | 23 | 1.9 (3.6) | 25 | 2.1 (9.9) | −0.1 | −2.7, 2.3 | 0.8 | |
| MVPA (min∙day−1) | Baseline | 35 | 20 (12) | 35 | 28 (24) | −7.8 | −17, 2.0 | 0.11 |
| Post-program | 23 | 26 (20) | 25 | 23 (26) | 2.7 | −0.6, 11 | 0.5 | |
| Steps per day | Baseline | 33 | 3984 (1519) | 34 | 4532 (3262) | − 548 | − 1713, 617 | 0.3 |
| Post-program | 22 | 4568 (2509) | 25 | 4620 (2825) | −52 | − 1474, 1369 | 0.9 | |
| Sedentary time (hours∙day−1) | Baseline | 35 | 8.2 (1.6) | 35 | 8.2 (1.6) | −0.0 | −0.7, 0.7 | 0.9 |
| Post-program | 23 | 8.3 (1.6) | 25 | 8.1 (1.6) | 0.1 | −0.8, 1.1 | 0.7 | |
Presented values are the mean ± SD. PA, physical activity. CPM, counts per minute. MVPA, moderate to vigorous physical activity. CI, confidence interval
Between-group difference in weight, BMI, waist circumference and body composition at baseline and post-program
| Intervention group | Comparison group | |||||||
|---|---|---|---|---|---|---|---|---|
| N | Mean (SD) | N | Mean (SD) | Mean diff | 95% CI | P | ||
| Weight (kg) | Baseline | 43 | 90.3 (21) | 39 | 88.6 (24) | 1.7 | −8.6, 12 | 0.7 |
| Post-program | 32 | 91.8 (21.3) | 37 | 88.3 (25) | 0.6 | −2.2, 1.0 | 0.4 | |
| BMI (kg/m2) | Baseline | 43 | 29.8 (5.8) | 39 | 29.3 (6.3) | 0.4 | −2.2, 3.1 | 0.7 |
| Post-program | 32 | 30.3 (5.8) | 37 | 29.3 (6.7) | 0.1 | 0.6, −0.4 | 0.6 | |
| Waist circumference (cm) | Baseline | 41 | 105 (16) | 37 | 104 (18) | 0.6 | 7, −8 | 0.8 |
| Post-program | 33 | 107 (15) | 34 | 103 (18) | 1.3 | 3, −0.7 | 0.19 | |
| Percent fat | Baseline | 43 | 30.5 (8.1) | 39 | 29.3 (10.6) | 1.1 | 3, −5 | 0.5 |
| Post-program | 32 | 30.7 (8.5) | 37 | 29.7 (11.1) | 0.0 | 0.9, −0.8 | 0.9 | |
| Fat mass (kg) | Baseline | 43 | 28.1 (10.8) | 39 | 27.5 (15.5) | 0.6 | 5, −6 | 0.8 |
| Post-program | 32 | 28.8 (11.2) | 37 | 27.9 (16.1) | 0.2 | 1.3, −0.8 | 0.6 | |
| Muscle mass (kg) | Baseline | 43 | 59.1 (14.0) | 39 | 58.0 (12.7) | 1.0 | 4, −6 | 0.7 |
| Post-program | 32 | 59.8 (13.2) | 37 | 57.4 (12.8) | 0.3 | 1.2, −0.4 | 0.3 | |
| Fat-free mass (kg) | Baseline | 43 | 62.2 (14.7) | 39 | 61.0 (13.2) | 1.2 | 4, −7 | 0.7 |
| Post-program | 32 | 62.9 (13.8) | 37 | 60.4 (13.4) | 0.2 | 1.1, −0.6 | 0.5 | |
| Visceral fat (kg) | Baseline | 41 | 9.7 (4.8) | 33 | 8.3 (5.0) | 1.4 | 0.8, −3 | 0.2 |
| Post-program | 30 | 9.4 (4.5) | 36 | 9.2 (6.4) | 0.1 | 0.6, −0.3 | 0.5 | |
Presented values are the mean ± SD. BMI, body mass index. CI, confidence interval